Individuals recently released from prison face a higher risk of death, particularly when they lack access to medication treatment for opioid use disorders. The transition from incarceration to the community is a period where medical support serves as an intervention.
The Mortality Risk Following Incarceration
The period immediately following release from a correctional facility is associated with an elevated risk of mortality. People released from US prisons that do not offer within-prison medication treatment for opioid use disorders are at greater risk in the first month post-release.
For those with opioid use disorders, the lack of access to treatment within prison walls exacerbates this vulnerability. Individuals who do not receive medication treatment while incarcerated are twice as likely to die following their release compared to those who received medical support.
Medication-Assisted Treatment as a Clinical Standard
Correctional health programs treat opioid use disorder. When these medications are integrated into the prison system and continued upon discharge, they provide a stabilization bridge.
Addressing Barriers to Care
- Logistical Challenges
- Funding Constraints
- Regulatory Hurdles
Key Considerations for Re-entry
The transition from incarceration involves more than just medical management; it requires a structured approach to social and health resources.
- Risk Timing: The greater risk is in the first month post-release.
- Clinical Impact: Continuity of care for opioid use disorders reduces the likelihood of death.
- Social Determinants: Re-entry success is tied to the ability to rebuild constructive family and social connections while avoiding criminal networks.
The prison experience functions as a major intervention.
Related reading